Clinical Trials Logo

Clinical Trial Summary

The investigators developed an ultra-speed picosecond laser (20ps) with a 20gHz repetition rate that provide very promising results in vitro and in ex vivo skin to remove skin tattoos.

The aim of this study is to evaluate the efficacy and tolerance of a new ultra-speed picosecond laser and to compare it to a nanosecond laser for treating black tattoos.

In a first phase of the study 10 patients with black tattoos will be treated with increasing fluencies of the picosecond laser to the optimal parameters in terms of efficacy and tolerance.

In a second phase, 10 additional subjects with black tattoos will be treated after central randomization on half of the tattoo with the picosecond laser (with the parameters determined in the first phase) and the other half treated with a nanosecond laser.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03386760
Study type Interventional
Source Centre Hospitalier Universitaire de Nice
Contact Thierry PASSERON, PhD
Phone +33492036488
Email passeron.t@chu-nice.fr
Status Recruiting
Phase Phase 1/Phase 2
Start date January 15, 2018
Completion date May 2020

See also
  Status Clinical Trial Phase
Terminated NCT03415685 - Lutronic PicoPlus Exploratory Clinical Trial N/A
Active, not recruiting NCT05248009 - Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy N/A
Active, not recruiting NCT02700932 - Clinical Study to Evaluate the Performance of the PicoWayTM 1064 nm/ 785 nm/ 532nm Picosecond Laser for Tattoo Removal N/A
Recruiting NCT06431464 - Tattoo Particles: Picosecond Laser Versus Nanosecond Laser
Completed NCT05877833 - Evaluating the Safety and Performance Characteristics of Ephemeral® Tattoo Ink in Healthy Subjects
Completed NCT03640819 - Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer N/A